ARDT

insider transactions

Ardent Health, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Cluster buy signal: 2 different insiders made open-market purchases in the last 90 days, totalling $186.4K.

Net shares · 90d

+21.3K

21.3K buy · 0 sell

Net value · 90d

$186.4K

$186.4K in · $0 out

Sentiment · 90d

Net buying

100% buying · 0% selling

Open-market trades · 90d

21.3K buy · 0 sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Buy·P
Jun 5, 26

Robert Demichiei

Director

$98.3K

11.3K sh · $8.73

Own +46%
Buy·P
Jun 5, 26

Alfred Lumsdaine KEY

Chief Financial Officer

$88.1K

10.0K sh · $8.81

Own +3%
Grant·A
Apr 1, 26

Peter J. Bulgarelli

Director

$0

14.2K sh

Own New
Grant·A
Apr 1, 26

Ellen Havdala

Director

$0

14.2K sh

Own +14%
Grant·A
Apr 1, 26

Mark R Sotir

Director

$0

14.2K sh

Own +58%
Grant·A
Apr 1, 26

Rahul Sen

Director

$0

14.2K sh

Own +58%
Grant·A
Apr 1, 26

Robert Thomas Webb

Director

$0

14.2K sh

Own +22%
Grant·A
Apr 1, 26

Edmondo Robinson

Director

$0

14.2K sh

Own +32%
Grant·A
Apr 1, 26

Robert Demichiei

Director

$0

14.2K sh

Own +141%
Grant·A
Apr 1, 26

William M Goodyear

Director

$0

14.2K sh

Own +14%
Grant·A
Apr 1, 26

Suzanne Campion

Director

$0

14.2K sh

Own +32%
Grant·A
Apr 1, 26

Peter C B Bynoe

Director

$0

14.2K sh

Own +14%
Grant·A
Apr 1, 26

Dave Caspers

Chief Operating Officer

$0

35.7K sh

Own +100%
Other·F
Apr 1, 26

Dave Caspers

Chief Operating Officer

$23.3K

2.7K sh · $8.67

Own -7%
Grant·A
Apr 1, 26

Stephen C. Petrovich

EVP, GC and Secretary

$0

24.9K sh

Own +3%
Other·F
Apr 1, 26

Stephen C. Petrovich

EVP, GC and Secretary

$15.7K

1.8K sh · $8.67

Own -0%
Grant·A
Apr 1, 26

David Raynor Byers

SVP & Chief Accounting Officer

$0

11.5K sh

Own +10%
Other·F
Apr 1, 26

David Raynor Byers

SVP & Chief Accounting Officer

$8.0K

924 sh · $8.67

Own -1%
Grant·A
Apr 1, 26

Alfred Lumsdaine KEY

Chief Financial Officer

$0

53.8K sh

Own +20%
Other·F
Apr 1, 26

Alfred Lumsdaine KEY

Chief Financial Officer

$38.0K

4.4K sh · $8.67

Own -2%
Grant·A
Apr 1, 26

Martin Bonick KEY

President and CEO

$0

134.6K sh

Own +10%
Other·F
Apr 1, 26

Martin Bonick KEY

President and CEO

$95.0K

11.0K sh · $8.67

Own -1%
Other·F
Mar 31, 26

Stephen C. Petrovich

EVP, GC and Secretary

$12.2K

1.4K sh · $8.56

Own -0%
Other·F
Mar 31, 26

David Raynor Byers

SVP & Chief Accounting Officer

$7.0K

819 sh · $8.56

Own -1%
Other·F
Mar 31, 26

Alfred Lumsdaine KEY

Chief Financial Officer

$21.5K

2.5K sh · $8.56

Own -1%
Other·F
Mar 31, 26

Martin Bonick KEY

President and CEO

$68.7K

8.0K sh · $8.56

Own -1%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 5, 2026	Robert Demichiei	Director	Buy P	11.3K	+46%	$8.73	$98.3K
Jun 5, 2026	Alfred Lumsdaine KEY	Chief Financial Officer	Buy P	10.0K	+3%	$8.81	$88.1K
Apr 1, 2026	Peter J. Bulgarelli	Director	Grant A	14.2K	New	—	$0
Apr 1, 2026	Ellen Havdala	Director	Grant A	14.2K	+14%	—	$0
Apr 1, 2026	Mark R Sotir	Director	Grant A	14.2K	+58%	—	$0
Apr 1, 2026	Rahul Sen	Director	Grant A	14.2K	+58%	—	$0
Apr 1, 2026	Robert Thomas Webb	Director	Grant A	14.2K	+22%	—	$0
Apr 1, 2026	Edmondo Robinson	Director	Grant A	14.2K	+32%	—	$0
Apr 1, 2026	Robert Demichiei	Director	Grant A	14.2K	+141%	—	$0
Apr 1, 2026	William M Goodyear	Director	Grant A	14.2K	+14%	—	$0
Apr 1, 2026	Suzanne Campion	Director	Grant A	14.2K	+32%	—	$0
Apr 1, 2026	Peter C B Bynoe	Director	Grant A	14.2K	+14%	—	$0
Apr 1, 2026	Dave Caspers	Chief Operating Officer	Grant A	35.7K	+100%	—	$0
Apr 1, 2026	Dave Caspers	Chief Operating Officer	Other F	2.7K	-7%	$8.67	$23.3K
Apr 1, 2026	Stephen C. Petrovich	EVP, GC and Secretary	Grant A	24.9K	+3%	—	$0
Apr 1, 2026	Stephen C. Petrovich	EVP, GC and Secretary	Other F	1.8K	-0%	$8.67	$15.7K
Apr 1, 2026	David Raynor Byers	SVP & Chief Accounting Officer	Grant A	11.5K	+10%	—	$0
Apr 1, 2026	David Raynor Byers	SVP & Chief Accounting Officer	Other F	924	-1%	$8.67	$8.0K
Apr 1, 2026	Alfred Lumsdaine KEY	Chief Financial Officer	Grant A	53.8K	+20%	—	$0
Apr 1, 2026	Alfred Lumsdaine KEY	Chief Financial Officer	Other F	4.4K	-2%	$8.67	$38.0K
Apr 1, 2026	Martin Bonick KEY	President and CEO	Grant A	134.6K	+10%	—	$0
Apr 1, 2026	Martin Bonick KEY	President and CEO	Other F	11.0K	-1%	$8.67	$95.0K
Mar 31, 2026	Stephen C. Petrovich	EVP, GC and Secretary	Other F	1.4K	-0%	$8.56	$12.2K
Mar 31, 2026	David Raynor Byers	SVP & Chief Accounting Officer	Other F	819	-1%	$8.56	$7.0K
Mar 31, 2026	Alfred Lumsdaine KEY	Chief Financial Officer	Other F	2.5K	-1%	$8.56	$21.5K
Mar 31, 2026	Martin Bonick KEY	President and CEO	Other F	8.0K	-1%	$8.56	$68.7K

About ARDT insider trading

This page tracks insider transactions for Ardent Health, Inc. (ARDT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.